Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Solid Biosciences (SLDB) Profit After Tax: 2017-2024

Historic Profit After Tax for Solid Biosciences (SLDB) over the last 7 years, with Dec 2024 value amounting to -$42.6 million.

  • Solid Biosciences' Profit After Tax fell 109.48% to -$42.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$124.7 million, marking a year-over-year decrease of 29.88%. This contributed to the annual value of -$124.7 million for FY2024, which is 29.88% down from last year.
  • Solid Biosciences' Profit After Tax amounted to -$42.6 million in Q4 2024, which was down 30.18% from -$32.7 million recorded in Q3 2024.
  • In the past 5 years, Solid Biosciences' Profit After Tax registered a high of -$15.2 million during Q4 2022, and its lowest value of -$42.6 million during Q4 2024.
  • For the 3-year period, Solid Biosciences' Profit After Tax averaged around -$25.6 million, with its median value being -$24.6 million (2023).
  • As far as peak fluctuations go, Solid Biosciences' Profit After Tax skyrocketed by 32.95% in 2020, and later crashed by 109.48% in 2024.
  • Over the past 4 years, Solid Biosciences' Profit After Tax (Quarterly) stood at -$21.4 million in 2020, then reached -$15.2 million in 2022, then slumped by 34.22% to -$20.3 million in 2023, then plummeted by 109.48% to -$42.6 million in 2024.
  • Its Profit After Tax was -$42.6 million in Q4 2024, compared to -$32.7 million in Q3 2024 and -$25.1 million in Q2 2024.